Clinical Trial Update: Open-Label Pilot Study With Crofelemer in Patients With Short Bowel Syndrome [EARLY_Phase 1]

View source ↗

Summary

An open-label, early-phase 1 pilot study of crofelemer in patients with short bowel syndrome is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Bowel Syndrome

Drugs mentioned

• Crofelemer (crofelemer)

Snippet

Sponsor: Lindsey Russell, MD | Conditions: Short Bowel Syndrome | EARLY_Phase 1 | Status: RECRUITING